Neurocrine Biosciences (NBIX) announced the appointment of Lewis Choi as Chief Information Officer, effective June 9. Choi, an accomplished leader with 25 years of experience in information technology and artificial intelligence, will be responsible for driving the vision and long-term strategic direction of the company’s technology initiatives. Choi joins Neurocrine after a 13-year career at Thermo Fisher Scientific (TMO), most recently as the Vice President of AI Automation & Data.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NBIX:
- Neurocrine announces new data from Phase 4 KINECT-PRO study
- Neurocrine Announces Leadership Transition with New CMO
- Neurocrine’s NBI-568 Clinical Advancements Justify Buy Rating Amid Competitive Efficacy and Strong Safety Profile
- Neurocrine’s NBI-1117568 shows new positive Phase 2 results in schizophrenia
- Neurocrine Holds Annual Meeting, Approves Key Matters